Thursday, August 20, 2009

So what is this HDIL-2 anyhow?

Here is a statement from their website: "PROLEUKIN therapy differs from other treatments for metastatic melanoma and metastatic kidney cancer because it's an immunotherapy. Instead of directly inhibiting cancer cells, it works to activate the body's immune system to help kill them."

This is important... renal cell carcinoma is not known for responding to typical chemotherapy.

No comments: